NSC |
Compound |
Enrichment |
Correlation |
NSC 711745 |
Null |
0.0112113991710615 |
0.45121033 |
NSC 718728 |
5-[2-(2,5-Dimethoxyphenyl)ethynyl]-2-methoxyphenyl-N- [2-(4-fluorophenyl)ethyl]carboxamide |
0.0112113991710615 |
0.43973764 |
NSC 728220 |
1-(3-Bromo-phenyl)-3-(pyridin-2-ylsulfanyl)-propenone |
0.0112113991710615 |
0.28432433 |
NSC 734562 |
6-(3-Aminopropyl)-9-bromo-5,6-dihydro-3-nitro-5,11-dioxo-11H -indeno[1,2-c]isoquinoline Hydrochloride |
0.0112113991710615 |
0.27057247 |
NSC 735540 |
5-fluoro-N-(2-methyl-3-oxo-8-phenyl-1-thia-4-azaspiro[4.5]de c-4-yl)-3-phenyl-1H-indole-2-carboxamide |
0.0112113991710615 |
0.34628152 |
NSC 741942 |
Null |
0.0112113991710615 |
0.61497521 |
NSC 744025 |
diethyl 2-[4-(5-[(11aS)-7-methoxy-5-oxo-2,3,5,11a-tetrahydro-1H-benzo[e]pyrrolo[1,2-a][1,4]diazepin-8-yl]oxypentyl)piperazino]ethylphosphonate |
0.0112113991710615 |
0.3958825 |
NSC 756166 |
GSK312948A |
0.0112113991710615 |
0.49561675 |
NSC 79563 |
1,3-bis(4-chlorobenzyl)-2-(phenanthren-9-yl)hexahydropyrimidine |
0.0112113991710615 |
0.32849023 |
NSC 174121 |
Methotrexate Derivative |
0.0112425217758228 |
0.36152011 |